13F Holdings
中文EN

RDNT RadNet, Inc.

Services-Medical Laboratories · Nasdaq · SEC CIK 790526 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY21.1%
TTM net income YoY-76.1%
TTM EPS YoY-81.3%
Revenue 3-yr CAGR14.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin3.1%
Net margin-0.9%
FCF margin—
EBITDA margin10.6%

Returns

ROE-2.1%
ROA-0.6%
ROIC (approx.)2.8%
Asset turnover0.60x

Leverage & solvency

Liabilities / assets66.4%
Debt / equity1.18x
Current ratio1.49x
Interest coverage0.99x

Cash quality & payout

Operating cash flow / net income-15.54x
Accruals ratio-9.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.04B$1.83B$1.62B$1.43B$1.32B
Operating income$61.99M$104.62M$98.70M$46.36M$82.55M
Interest expense$69.91M$79.85M$64.48M$50.84M$48.83M
Pretax income$31.91M$44.86M$38.81M$42.97M$58.88M
Income tax$14.86M$6.03M$8.47M$9.36M$14.56M
Net income-$18.65M$2.79M$3.04M$10.65M$24.73M
EBITDA$214.12M$242.46M$227.09M$162.24M$179.25M
EPS (basic)-0.250.040.050.190.47
EPS (diluted)-0.250.040.050.170.46
Weighted avg. shares (diluted)75.19M74.76M64.66M57.32M53.42M
Balance sheet
Cash & equivalents$767.22M$740.02M$342.57M$127.83M$134.61M
Receivables$200.32M$185.82M$163.71M$166.36M$135.06M
Current assets$1.03B$1.02B$579.28M$367.18M$324.26M
PP&E, net$807.70M$694.79M$604.40M$565.96M$484.25M
Goodwill$907.66M$710.66M$679.46M$677.66M$513.82M
Intangibles$148.51M$81.35M$90.61M$106.23M$56.60M
Total assets$3.76B$3.29B$2.69B$2.43B$2.06B
Current liabilities$586.76M$479.71M$437.45M$466.72M$374.78M
Short-term debt$25.42M$24.69M$17.97M$12.40M$11.16M
Long-term debt$1.06B$991.57M$812.07M$839.34M$743.50M
Total debt$1.09B$1.02B$830.04M$851.74M$754.66M
Total liabilities$2.40B$2.15B$1.88B$1.94B$1.71B
Shareholders' equity$1.09B$902.31M$630.70M$333.00M$228.90M
Net debt$322.70M$276.25M$487.47M$723.91M$620.06M
Shares outstanding77.40M74.04M67.96M57.72M53.55M
Cash flow statement
Operating cash flow$298.82M$233.02M$220.86M$146.42M$149.49M
Investing cash flow-$343.87M-$233.07M-$201.47M-$246.95M-$221.51M
Financing cash flow$72.21M$397.95M$195.63M$93.65M$104.67M
Depreciation & amortization$152.13M$137.84M$128.39M$115.88M$96.69M
Stock-based compensation$54.60M$29.83M$26.79M$23.77M$25.20M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.